↓ Skip to main content

Aplastic anemia secondary to adjuvant Osimertinib therapy: a case report and a review of literature

Overview of attention for article published in Frontiers in oncology, February 2024
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
3 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Aplastic anemia secondary to adjuvant Osimertinib therapy: a case report and a review of literature
Published in
Frontiers in oncology, February 2024
DOI 10.3389/fonc.2024.1275275
Pubmed ID
Authors

Ahmed Abdalhadi, Nabil E. Omar, Samah Kohla, Hassan Aakel, Yeslem Ekeibed, Reyad Mohsen

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 3 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 3 100%

Demographic breakdown

Readers by professional status Count As %
Lecturer 1 33%
Unknown 2 67%
Readers by discipline Count As %
Nursing and Health Professions 1 33%
Unknown 2 67%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 February 2024.
All research outputs
#20,423,743
of 25,971,360 outputs
Outputs from Frontiers in oncology
#9,566
of 22,848 outputs
Outputs of similar age
#222,847
of 344,896 outputs
Outputs of similar age from Frontiers in oncology
#235
of 827 outputs
Altmetric has tracked 25,971,360 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,848 research outputs from this source. They receive a mean Attention Score of 2.9. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 344,896 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 827 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.